What is Viking Therapeutics's stock issuance proceeds?

Viking Therapeutics (VKTX) reported stock issuance proceeds of $450K in Q1 2026.

How has Viking Therapeutics's stock issuance proceeds changed year-over-year?

Viking Therapeutics's stock issuance proceeds increased by 28.9% year-over-year, from $349K to $450K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Viking Therapeutics VKTX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Crinetics PharmaceuticalsCRNX

$380.51M—

Beam TherapeuticsBEAM

$2.03M+182%

Rhythm Pharmaceuticals, Inc.RYTM

$0-100%

Travere Therapeutics, Inc.TVTX

$4.73M+11.5%

Arcus BiosciencesRCUS

$0-100%

Madrigal Pharmaceuticals, Inc.MDGL

——

Other financials

Income statement

See full

Revenue-—

Operating income-$164.1M-196%

Net income-$158.3M-247%

EPS (diluted)-$1.37-234%

Balance sheet

See full

Cash & equivalents$118.1M+211%

Total debt$137.0K-87.8%

Total equity$501.9M-40.7%

Total assets$608.2M-29.8%

Cash flow

See full

Operating cash flow-$114.0M-118%

Valuation

See full

Market cap$4.04B+38.7%

Returns & leverage

See full

Return on equity-70%-94.5pp

Debt / equity0×0.0×

Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viking Therapeutics's stock issuance proceeds?: Viking Therapeutics (VKTX) reported stock issuance proceeds of $450K in Q1 2026.
How has Viking Therapeutics's stock issuance proceeds changed year-over-year?: Viking Therapeutics's stock issuance proceeds increased by 28.9% year-over-year, from $349K to $450K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.